125 related articles for article (PubMed ID: 22304485)
1. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats.
Mesripour A; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):75-80. PubMed ID: 22304485
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.
Miric G; Dallemagne C; Endre Z; Margolin S; Taylor SM; Brown L
Br J Pharmacol; 2001 Jul; 133(5):687-94. PubMed ID: 11429393
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.
Bostick B; Habibi J; DeMarco VG; Jia G; Domeier TL; Lambert MD; Aroor AR; Nistala R; Bender SB; Garro M; Hayden MR; Ma L; Manrique C; Sowers JR
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1126-35. PubMed ID: 25747754
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats.
Gallego M; Espiña L; Vegas L; Echevarria E; Iriarte MM; Casis O
Pharmacol Res; 2001 Oct; 44(4):311-5. PubMed ID: 11592866
[TBL] [Abstract][Full Text] [Related]
9. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
10. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
Hayashi M
J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
O'Brien D; Chunduri P; Iyer A; Brown L
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction.
Bender SB; DeMarco VG; Padilla J; Jenkins NT; Habibi J; Garro M; Pulakat L; Aroor AR; Jaffe IZ; Sowers JR
Hypertension; 2015 May; 65(5):1082-8. PubMed ID: 25712719
[TBL] [Abstract][Full Text] [Related]
15. Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
Mori T; Kurumazuka D; Matsumoto C; Shirakawa H; Kimura S; Kitada K; Kobayashi K; Matsuda H; Hayashi T; Kitaura Y; Matsumura Y
Eur J Pharmacol; 2009 Nov; 623(1-3):84-8. PubMed ID: 19766104
[TBL] [Abstract][Full Text] [Related]
16. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
17. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Arai K; Tsuruoka H; Homma T
Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats.
Simko F; Pechanova O; Krajcirovicova K; Matuskova J; Pelouch V; Adamcova M; Paulis L
Int J Cardiol; 2015; 190():128-30. PubMed ID: 25918064
[No Abstract] [Full Text] [Related]
19. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
[TBL] [Abstract][Full Text] [Related]
20. The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction.
Marques Neto SR; da H Silva A; dos Santos MC; Ferraz EF; Nascimento JH
Acta Physiol (Oxf); 2013 Jun; 208(2):166-71. PubMed ID: 23279762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
